ExodusPoint Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History

ExodusPoint Capital Management’s Portfolio RXRX Stock Details RXRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1M	Buy
2025 Q2	$230K	Buy
2024 Q2	–	Sell
2024 Q1	$615K	Buy
2023 Q2	–	Sell
2023 Q1	$208K	Buy
2022 Q4	–	Sell
2022 Q3	$488K	Sell
2022 Q2	$1.56M	Buy
2022 Q1	$241K	Buy